WO2002092818A3 - Sequence du genome streptococcus agalactiae et ses utilisations - Google Patents

Sequence du genome streptococcus agalactiae et ses utilisations Download PDF

Info

Publication number
WO2002092818A3
WO2002092818A3 PCT/IB2002/003059 IB0203059W WO02092818A3 WO 2002092818 A3 WO2002092818 A3 WO 2002092818A3 IB 0203059 W IB0203059 W IB 0203059W WO 02092818 A3 WO02092818 A3 WO 02092818A3
Authority
WO
WIPO (PCT)
Prior art keywords
genome sequence
therapeutic targets
streptococcus agalactiae
diagnostic tools
identifying therapeutic
Prior art date
Application number
PCT/IB2002/003059
Other languages
English (en)
Other versions
WO2002092818A8 (fr
WO2002092818A2 (fr
Inventor
Philippe Glaser
Christophe Rusniok
Fabien Chevalier
Lionel Frangeul
Lila Lalioui
Mohamed Zouine
Elisabeth Couve
Carmen Buchrieser
Claire Poyart
Patrick Trieu-Cuot
Frank Kunst
Original Assignee
Pasteur Institut
Centre Nat Rech Scient
Philippe Glaser
Christophe Rusniok
Fabien Chevalier
Lionel Frangeul
Lila Lalioui
Mohamed Zouine
Elisabeth Couve
Carmen Buchrieser
Claire Poyart
Patrick Trieu-Cuot
Frank Kunst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Centre Nat Rech Scient, Philippe Glaser, Christophe Rusniok, Fabien Chevalier, Lionel Frangeul, Lila Lalioui, Mohamed Zouine, Elisabeth Couve, Carmen Buchrieser, Claire Poyart, Patrick Trieu-Cuot, Frank Kunst filed Critical Pasteur Institut
Priority to AU2002319867A priority Critical patent/AU2002319867A1/en
Publication of WO2002092818A2 publication Critical patent/WO2002092818A2/fr
Publication of WO2002092818A3 publication Critical patent/WO2002092818A3/fr
Publication of WO2002092818A8 publication Critical patent/WO2002092818A8/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention a pour objet la séquence génomique et des séquences nucléotidiques codant pour des polypeptides de Streptococcus agalactiae, tels que des polypeptides d'enveloppe cellulaire, ou des polypeptides sécrétés ou spécifiques, ou impliqués dans le métabolisme et dans le processus de réplication, ainsi que des vecteurs ou cellules incluant lesdites séquences. L'invention porte également sur leur application au développement de vaccins, d'outils de diagnostic, de puces à ADN et à l'identification de cibles thérapeutiques.
PCT/IB2002/003059 2001-04-26 2002-04-26 Sequence du genome streptococcus agalactiae et ses utilisations WO2002092818A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002319867A AU2002319867A1 (en) 2001-04-26 2002-04-26 Streptococcus agalactiae genome sequence, use for developing vaccines, diagnostic tools, and for identifying therapeutic targets

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2001/05642 2001-04-26
FR0105642A FR2824074A1 (fr) 2001-04-26 2001-04-26 Sequence du genome streptococcus agalactiae, application au developpement de vaccins, d'outils de diagnostic, et a l'identification de cibles therapeutiques

Publications (3)

Publication Number Publication Date
WO2002092818A2 WO2002092818A2 (fr) 2002-11-21
WO2002092818A3 true WO2002092818A3 (fr) 2003-08-28
WO2002092818A8 WO2002092818A8 (fr) 2004-03-04

Family

ID=8862732

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2002/003059 WO2002092818A2 (fr) 2001-04-26 2002-04-26 Sequence du genome streptococcus agalactiae et ses utilisations

Country Status (3)

Country Link
AU (1) AU2002319867A1 (fr)
FR (1) FR2824074A1 (fr)
WO (1) WO2002092818A2 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
MXPA03003690A (es) 2000-10-27 2004-05-05 Chiron Spa Acidos nucleicos y proteinas de los grupos a y b de estreptococos.
US7691571B2 (en) 2001-01-31 2010-04-06 Mayo Foundation For Medical Education And Research Detection of bordetella
EP1362106B1 (fr) 2001-02-21 2010-01-27 ID Biomedical Corporation Polypeptides de streptococcus pyogenes et fragments d'adn correspondants
ATE452191T1 (de) 2001-07-06 2010-01-15 Id Biomedical Corp Gruppe-b streptococcus antigene und entsprechende dna-fragmente
GB0210128D0 (en) * 2002-05-02 2002-06-12 Chiron Spa Nucleic acids and proteins from streptococcus groups A & B
US7601804B2 (en) 2002-08-12 2009-10-13 Intervet International B.V. Streptococcus uberis protein, nucleic acid sequence encoding the same and its use in a mastitis vaccine
US7074598B2 (en) 2002-09-25 2006-07-11 Mayo Foundation For Medical Education And Research Detection of vancomycin-resistant enterococcus spp.
US7365176B2 (en) 2002-09-26 2008-04-29 Mayo Foundation For Medical Education And Research Detection of Epstein-Barr virus
JP5116971B2 (ja) 2002-10-15 2013-01-09 インターセル アーゲー Ｂ群連鎖球菌の接着因子をコードする核酸、ｂ群連鎖球菌の接着因子、およびその使用
CN1756843B (zh) * 2003-03-04 2012-03-21 英特塞尔股份公司 化脓链球菌抗原
EP2311988A1 (fr) 2003-04-15 2011-04-20 Intercell AG Antigènes de S. pneumoniae
WO2004099242A2 (fr) * 2003-05-07 2004-11-18 Intercell Ag Antigènes i + ii contre s. agalactiae
EP1648500B1 (fr) 2003-07-31 2014-07-09 Novartis Vaccines and Diagnostics, Inc. Compositions immunogenes pour streptoccus pyogenes
EP1663303B1 (fr) * 2003-09-15 2011-05-04 Novartis Vaccines and Diagnostics, Inc. Compositions immunogenes pour streptococcus agalactiae
US8945589B2 (en) 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
WO2005052145A2 (fr) * 2003-10-07 2005-06-09 University Of Florida Bacteries alcalinisantes de recombinaison
US7427475B2 (en) 2003-11-18 2008-09-23 Mayo Foundation For Medical Education And Research Detection of group B streptococcus
EP2612679A1 (fr) * 2004-07-29 2013-07-10 Novartis Vaccines and Diagnostics, Inc. Compositions immunogènes pour une bactérie à gram positif telle que streptococcus agalactiae
CA2591510A1 (fr) * 2004-12-22 2006-06-29 Novartis Vaccines And Diagnostics, Inc. Streptococcus du groupe b
EP1861414B9 (fr) 2005-02-07 2011-04-06 Gen-Probe Incorporated Compositions et procedes pour detecter des streptocoques du groupe b
JP5219803B2 (ja) * 2005-05-13 2013-06-26 ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド グラム陽性菌の血清耐性因子
US20100261618A1 (en) * 2006-06-19 2010-10-14 Sonia Escaich Identification of genes implicated in the virulence of streptococcus agalactiae
EP2292646A3 (fr) * 2006-07-07 2011-06-08 Intercell AG Petits antigènes pyogènes streptococcus et leur utilisation
KR101621837B1 (ko) 2007-09-12 2016-05-17 노파르티스 아게 Ｇａｓ57 돌연변이 항원 및 ｇａｓ57 항체
AU2009313808B2 (en) 2008-11-14 2013-05-16 Gen-Probe Incorporated Compositions, kits and methods for detection of campylobacter nucleic acid
US8877909B2 (en) 2011-04-04 2014-11-04 Intelligent Medical Devices, Inc. Optimized oligonucleotides and methods of using same for the detection, isolation, amplification, quantitation, monitoring, screening, and sequencing of group B Streptococcus
EP2557424A1 (fr) 2011-08-11 2013-02-13 InGen Biosciences Procédé pour le diagnostic d'infections par les genres Streptococcus, Enterococcus et Pepstostreptococcus
AU2013224026A1 (en) * 2012-02-24 2014-08-21 Novartis Ag Pilus proteins and compositions
AU2017214441B2 (en) * 2016-02-04 2021-08-19 Genovis Ab New Streptococcal proteases
PL239045B1 (pl) * 2018-01-09 2021-11-02 Inst Immunologii I Terapii Doswiadczalnej Polskiej Akademii Nauk Epitop specyficzny dla zakaźnych Streptococcus agalactiae oraz sposób wykrywania zakażenia pacjenta szczepem Streptococcus agalactiae

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001014421A1 (fr) * 1999-08-25 2001-03-01 Medimmune, Inc. Homologues d'une proteine pneumococcique et fragments pour vaccins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2000001886A0 (en) * 1998-02-20 2000-09-30 Iaf Biochem Int Group B streptococcus antigens.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001014421A1 (fr) * 1999-08-25 2001-03-01 Medimmune, Inc. Homologues d'une proteine pneumococcique et fragments pour vaccins

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 11 February 1999 (1999-02-11), SPELLERBERG B. ET AL.: "Streptococcus agalactiae Lmb (lmb) gene, complete cds; and unknown gene", XP002221154, Database accession no. AF062533 *
DATABASE SWALL [online] 1 March 2001 (2001-03-01), DE BOEVER, E.H. ET AL.: "TraG-related protein", XP002221155, Database accession no. Q9F1G0 *
DORAN, T. I. ET AL.: "Factors Influencing Release of Type III Antigens by Group B Streptococci", INFECT. IMMUN., vol. 31, no. 2, February 1981 (1981-02-01), pages 615 - 623, XP002191322 *
ERIKA H. DE BOEVER ET AL.: "Enterococcus faecalis conjugative plasmid pAM373: complete nucleotide sequence and genetic analysis of sex phromone response", MOLECULAR MICROBIOLOGY, vol. 37, no. 6, 2000, pages 1327 - 1341 *
SPELLERBERG B ET AL: "LMB, A PROTEIN WITH SIMILARITIES TO THE LRAI ADHESIN FAMILY, MEDIATES ATTACHMENT OF STREPTOCOCCUS AGALACTIAE TO HUMAN LAMININ", INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY. WASHINGTON, US, vol. 67, no. 2, AF062533, February 1999 (1999-02-01), pages 871 - 878, XP000973065, ISSN: 0019-9567 *

Also Published As

Publication number Publication date
WO2002092818A8 (fr) 2004-03-04
AU2002319867A1 (en) 2002-11-25
WO2002092818A2 (fr) 2002-11-21
FR2824074A1 (fr) 2002-10-31

Similar Documents

Publication Publication Date Title
WO2002092818A3 (fr) Sequence du genome streptococcus agalactiae et ses utilisations
WO2003016475A3 (fr) Sequences d'acides nucleiques et d'acides amines intervenant dans la douleur
WO2004047863A3 (fr) Produits geniques exprimes de maniere differentielle dans des tumeurs et leur utilisation
MXPA02012743A (es) Moleculas tipo il-17 y usos de las mismas.
WO2002014358A3 (fr) Nouvelles proteines secretees et leurs utilisations
WO2004101760A3 (fr) Une nouvelle enzyme lipolytique dite elip
CA2295999A1 (fr) Proteines nik, acides nucleiques et procedes correspondants
WO2001077335A3 (fr) Genome de listeria monocytogenes, polypeptides et utilisations
WO2004096842A3 (fr) Sequences de nucleotides et d'acides amines du virus du sras, et utilisations associees
WO2001068859A3 (fr) Molecules du type recepteur de l'interleukine 17 et leur utilisation
WO2002062999A3 (fr) Proteines et acides nucleiques codant pour celles-ci
WO2001068705A3 (fr) Molecules du type recepteur de l'interleukine 17 et leurs utilisations
WO2004046365A3 (fr) Polypeptides et conjugues interferon-alpha
WO2002059315A3 (fr) Nouveaux acides nucleiques et polypeptides et procedes de leur utilisation
CA2294566A1 (fr) Proteines ikk-.alpha., acides nucleiques et procedes
WO2003016551A3 (fr) Proteine de liaison a l'acide salicylique codant des acides nucleiques, proteine de liaison a l'acide salicylique 2 (sabp2) et methodes d'utilisation associees
WO1999054447A3 (fr) Sequences d'acide nucleique provenant de tissus tumoraux de la vessie
WO2003062453A3 (fr) Acides nucleiques et proteines associes a la polykystose renale
WO2000058352A3 (fr) Gene d'orge pour reductase de thioredoxine et de thioredoxine nadp
PL374550A1 (en) Il-17 like molecules and uses thereof
WO2002085922A3 (fr) Proteines et acides nucleiques codant pour celles-ci
WO2001053453A8 (fr) Nouveaux acides nucleiques de moelle osseuse et polypeptides associes
WO2003018629A8 (fr) Antigene cage
WO2002016578A3 (fr) Nouvelles proteines secretees et procedes d'utilisation de ces dernieres
WO2001002429A3 (fr) Angiopoietine 6 et ses utilisations

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 47/2002 ADD "DECLARATION UNDER RULE 4.17: - OF INVENTORSHIP (RULE 4.17(IV)) FOR US ONLY."

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP